Skip to main content

Table 1 Disease areas covered by included systematic reviews (the HTA data were collected for this study; the other data are from Page et al. [1])

From: Nature and reporting characteristics of UK health technology assessment systematic reviews

Disease area HTAs 2004 & 2014 Systematic reviews 2004 [1]a Systematic reviews 2014 [1]a
Neoplasms (i.e. cancers, carcinomas, tumours) 8 (16%) 22 (7%) 49 (16%)
Diseases of the circulatory system 8 (16%) 33 (11%) 34 (11%)
Endocrine, nutritional or metabolic disease 7 (14%) NR 23 (8%)
Mental and Behavioural 5 (10%) 40 (13%) 22 (7%)
Infections and parasitic diseases 3 (6%) 22 (7%) 41 (14%)
Diseases of the nervous system 3 (6%) NR NR
Musculoskeletal 3 (6%) NR 20 (7%)
Diseases of the eye and adnexa 2 (4%) NR NR
External causes of mortality and morbidity 2 (4%) NR NR
Genito-urinary 2 (4%) NR NR
Diseases of the digestive system 2 (4%) 20 (7%) 25 (8%)
Ear and mastoid process 1 (2%) NR NR
Pregnancy and birth 1 (2%) NR NR
Blood 1 (2%) NR NR
Skin and subcutaneous tissue 1 (2%) NR NR
Congenital malformations 1 (2%) NR NR
Total 50 (100%) 137b 214b
  1. HTA Health Technology Assessment; aAs reported by Page et al. [1] bPage et al. did not report values less than 7% so not all 300 systematic reviews are included; NR: Not reported